Shoaib Hassan
Biographic Data
| ID | 3914442 |
|---|---|
| NAME | Shoaib Hassan |
| GIVEN NAMES | Shoaib |
| FAMILY NAME | Hassan |
| SIGNATURE | HASSAN S |
| AFFILIATIONS | University of Bergen |
| ORCID | 0000-0002-4487-4020 |
| VERIFIED | Yes |
| TOTAL WORKS | 10 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 10 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
The catastrophic financial burden of extrapulmonary tuberculosis and asset index-based inequality analysis: A prospective cohort study analysing patients’ impoverishment
This prospective cohort study assessed the financial burden of extrapulmonary tuberculosis (EPTB) in India, revealing substantial costs across disease manifestations. Among 200 confirmed EPTB patients, those with pleuritis, meningitis, and other severe forms, incurred significantly higher out-of-pocket (OOP) and indirect costs than lymphadenitis patients. Over 90% of meningitis and 80% of pleuritis patients experienced catastrophic health expendi…
Global burden of bacterial antimicrobial resistance 1990–2021: A systematic analysis with forecasts to 2050
BACKGROUND: Antimicrobial resistance (AMR) poses an important global health challenge in the 21st century. A previous study has quantified the global and regional burden of AMR for 2019, followed with additional publications that provided more detailed estimates for several WHO regions by country. To date, there have been no studies that produce comprehensive estimates of AMR burden across locations that encompass historical trends and future for…
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021
BACKGROUND: Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by…
Comparing the cost-effectiveness of the MPT64-antigen detection test to Xpert MTB/RIF and ZN-microscopy for the diagnosis of Extrapulmonary Tuberculosis: An economic evaluation modelling study
Extrapulmonary Tuberculosis (EPTB) poses challenges from patient and health system perspectives. The cost-effectiveness analysis of the Xpert MTB/RIF (Xpert) test to diagnose pulmonary tuberculosis is documented. However, there are no economic evaluations for EPTB. Considering the reported better diagnostic sensitivity of the MPT64 test, this study explored its cost-effectiveness as an alternative diagnostic test. We conducted this economic evalu…
Innovation Spillovers, Economic Growth, and the Role of Absorptive Ability
Research and Development (R&D) based economic sustainability is the prime area of concern in endogenous growth framework to solve the problem of production inefficiency for attaining the economic stability. The high Total Factor Productivity (TFP) growth can be attained through green technology, reverse engineering, ‘learning by doing’ and artificial intelligence. The foreign and domestic green R&D innovation adoption and its spillovers are relyi…
Impact of the 2008 economic crisis on the burden of hepatitis B and C diseases in Southern European countries
Epidemiological metrics for HBV and HCV showed a slower pace of decline in the post-austerity period with better improvement for HBV, a stabilisation of mortality and a stagnant burden for liver cancer due to both hepatitis infections. The economic crisis of 2008 had a negative impact on the burden of hepatitis B and C. Elimination of HBV and HCV by 2030 will be a major challenge in the SWE countries
Health-related quality of life among extrapulmonary tuberculosis patients and inequalities by disease manifestations: A longitudinal study analysing the impact of TB treatment
Despite post-treatment improvement in health, inequality of reported health states by EPTB manifestations persisted, though decreased. This highlights that holistic patient- and health system-level interventions addressing the impact of illness should consider EPTB by its manifestations, not as a single disease entity
Financial Inclusion and Economic Growth: Comparative Panel Evidence from Developed and Developing Asian Countries
We investigate the empirical nexus between financial inclusion and economic growth for an extended sample of 21 Asian countries spanning over a period from 2004 to 2019. Further, we also conducted a sub-sample analysis by dividing the overall samples into developed and developing countries. Our results reveal a significant positive long-term impact of financial inclusion on economic growth in Asia. Our pair-wise causality test shows bidirectional…
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD burden, including 13 underlying causes of cardiovascular death and 9 related risk factors, using estimates from the Global Burden of Disease (GBD) Study 2019. GBD, an ongoing multinational collaboration to provide comparable and consisten…
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study…
BACKGROUND: Achieving universal health coverage (UHC) involves all people receiving the health services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by the agenda of the UN Sustainable Development Goals (SDGs) and WHO's Thirteenth General Programme of Work (GPW13). Measuring effective coverage at the health-system le…
No prominent works on this page.
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD burden, including 13 underlying causes of cardiovascular death and 9 related risk factors, using estimates from the Global Burden of Disease (GBD) Study 2019. GBD, an ongoing multinational collaboration to provide comparable and consisten…
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study…
BACKGROUND: Achieving universal health coverage (UHC) involves all people receiving the health services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by the agenda of the UN Sustainable Development Goals (SDGs) and WHO's Thirteenth General Programme of Work (GPW13). Measuring effective coverage at the health-system le…
Global burden of bacterial antimicrobial resistance 1990–2021: A systematic analysis with forecasts to 2050
BACKGROUND: Antimicrobial resistance (AMR) poses an important global health challenge in the 21st century. A previous study has quantified the global and regional burden of AMR for 2019, followed with additional publications that provided more detailed estimates for several WHO regions by country. To date, there have been no studies that produce comprehensive estimates of AMR burden across locations that encompass historical trends and future for…
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021
BACKGROUND: Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by…
Comparing the cost-effectiveness of the MPT64-antigen detection test to Xpert MTB/RIF and ZN-microscopy for the diagnosis of Extrapulmonary Tuberculosis: An economic evaluation modelling study
Extrapulmonary Tuberculosis (EPTB) poses challenges from patient and health system perspectives. The cost-effectiveness analysis of the Xpert MTB/RIF (Xpert) test to diagnose pulmonary tuberculosis is documented. However, there are no economic evaluations for EPTB. Considering the reported better diagnostic sensitivity of the MPT64 test, this study explored its cost-effectiveness as an alternative diagnostic test. We conducted this economic evalu…
Innovation Spillovers, Economic Growth, and the Role of Absorptive Ability
Research and Development (R&D) based economic sustainability is the prime area of concern in endogenous growth framework to solve the problem of production inefficiency for attaining the economic stability. The high Total Factor Productivity (TFP) growth can be attained through green technology, reverse engineering, ‘learning by doing’ and artificial intelligence. The foreign and domestic green R&D innovation adoption and its spillovers are relyi…
Impact of the 2008 economic crisis on the burden of hepatitis B and C diseases in Southern European countries
Epidemiological metrics for HBV and HCV showed a slower pace of decline in the post-austerity period with better improvement for HBV, a stabilisation of mortality and a stagnant burden for liver cancer due to both hepatitis infections. The economic crisis of 2008 had a negative impact on the burden of hepatitis B and C. Elimination of HBV and HCV by 2030 will be a major challenge in the SWE countries
Health-related quality of life among extrapulmonary tuberculosis patients and inequalities by disease manifestations: A longitudinal study analysing the impact of TB treatment
Despite post-treatment improvement in health, inequality of reported health states by EPTB manifestations persisted, though decreased. This highlights that holistic patient- and health system-level interventions addressing the impact of illness should consider EPTB by its manifestations, not as a single disease entity
Financial Inclusion and Economic Growth: Comparative Panel Evidence from Developed and Developing Asian Countries
We investigate the empirical nexus between financial inclusion and economic growth for an extended sample of 21 Asian countries spanning over a period from 2004 to 2019. Further, we also conducted a sub-sample analysis by dividing the overall samples into developed and developing countries. Our results reveal a significant positive long-term impact of financial inclusion on economic growth in Asia. Our pair-wise causality test shows bidirectional…
The catastrophic financial burden of extrapulmonary tuberculosis and asset index-based inequality analysis: A prospective cohort study analysing patients’ impoverishment
This prospective cohort study assessed the financial burden of extrapulmonary tuberculosis (EPTB) in India, revealing substantial costs across disease manifestations. Among 200 confirmed EPTB patients, those with pleuritis, meningitis, and other severe forms, incurred significantly higher out-of-pocket (OOP) and indirect costs than lymphadenitis patients. Over 90% of meningitis and 80% of pleuritis patients experienced catastrophic health expendi…
Medicine (7 works) · Environmental health (5 works) · Pathology (4 works) · Demography (3 works) · Diagnosis and treatment of tuberculosis (3 works) · Disease (3 works) · Disease burden (3 works) · Internal Medicine (3 works) · Population (3 works) · Public health (3 works)